NCT03027232View on ClinicalTrials.gov

Control of Leukocyte Function

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions

Inflammation, Brain

Interventions

OTHER

No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies

No drugs or interventions are given. Single purpose is to draw blood from healthy subjects to study immune cell biology in vitro. No records about subjects to be kept.

Trial Locations (1)

02215

BIDMC, Boston

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

NCT03027232 - Control of Leukocyte Function | Biotech Hunter | Biotech Hunter